Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2012 (Vol. 32, No. 1)

Tips on Expertly Navigating the Biosimilar Terrain

  • The Biologics Price Competition and Innovation (BPCI) Act, a subtitle of the Affordable Care Act (ACA), amends the existing policy on biological drugs, the Public Health Service Act (PHS), to create a provision for the rapid approval of biosimilar drugs. The FDA defines “biosimilar” as a drug that is ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.